Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of Ertugliflozin on Kidney Outcomes in Patients With Heart Failure at Baseline in the Evaluation of Ertugliflozin Efficacy and Safety Cardiovascular Outcomes (VERTIS CV) Trial.
Cherney DZI, Cosentino F, McGuire DK, Kolkailah AA, Dagogo-Jack S, Pratley RE, Frederich R, Maldonado M, Liu CC, Cannon CP; VERTIS CV Investigators. Cherney DZI, et al. Among authors: kolkailah aa. Kidney Int Rep. 2023 Jan 20;8(4):746-753. doi: 10.1016/j.ekir.2023.01.011. eCollection 2023 Apr. Kidney Int Rep. 2023. PMID: 37069970 Free PMC article.
Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin: A Secondary Analysis of Randomized Clinical Trials.
Marx N, Kolkailah AA, Rosenstock J, Johansen OE, Cooper ME, Alexander JH, Toto RD, Wanner C, Espeland MA, Mattheus M, Schnaidt S, Perkovic V, Gollop ND, McGuire DK. Marx N, et al. Among authors: kolkailah aa. JAMA Cardiol. 2024 Feb 1;9(2):134-143. doi: 10.1001/jamacardio.2023.4602. JAMA Cardiol. 2024. PMID: 38170502 Free PMC article.
Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial.
Pandey A, Kolkailah AA, Cosentino F, Cannon CP, Frederich RC, Cherney DZI, Dagogo-Jack S, Pratley RE, Cater NB, Gantz I, Mancuso JP, McGuire DK. Pandey A, et al. Among authors: kolkailah aa. Eur Heart J. 2023 Dec 21;44(48):5163-5166. doi: 10.1093/eurheartj/ehad639. Eur Heart J. 2023. PMID: 37864578 Free PMC article. No abstract available.
Longitudinal Trends in Cardiovascular Risk Factor Profiles and Complications Among Patients Hospitalized for COVID-19 Infection: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry.
Hall EJ, Ayers CR, Kolkailah AA, Rutan C, Walchok J, Williams JH 4th, Wang TY, Rodriguez F, Bradley SM, Stevens L, Hall JL, Mallya P, Roth GA, Morrow DA, Elkind MSV, Das SR, de Lemos JA. Hall EJ, et al. Among authors: kolkailah aa. Circ Cardiovasc Qual Outcomes. 2023 May;16(5):e009652. doi: 10.1161/CIRCOUTCOMES.122.009652. Epub 2023 Apr 5. Circ Cardiovasc Qual Outcomes. 2023. PMID: 37017087 Free PMC article.
Effects of once-weekly subcutaneous semaglutide on coronary artery disease outcomes in patients with type 2 diabetes with or at high risk for cardiovascular disease: Insights from the SUSTAIN-6 trial.
Kolkailah AA, Lingvay I, Dobrecky-Mery I, Aharonovich A, David JP, Holse C, Rasmussen S, McGuire DK. Kolkailah AA, et al. Diabetes Obes Metab. 2023 Apr;25(4):1117-1120. doi: 10.1111/dom.14941. Epub 2022 Dec 23. Diabetes Obes Metab. 2023. PMID: 36514266 Free PMC article. No abstract available.
41 results